Table 3.
Treatment details.
| Radiation therapy details (n = 53) | |||
|---|---|---|---|
| Dose-fractionation schema to GTV | n | % | |
| 36 Gy/12–14 fx | 4 | 8 % | |
| 37.5 Gy/15 fx | 5 | 9 % | |
| 39 Gy/12–13 fx | 2 | 4 % | |
| 41–42 Gy/12–15 fx | 4 | 8 % | |
| 42.5 Gy/17 fx | 4 | 8 % | |
| 45 Gy/14–15 fx | 22 | 42 % | |
| 45.5 Gy/14 fx | 1 | 2 % | |
| 48 Gy/15 fx | 1 | 2 % | |
| 52.5 Gy/15 fx | 10 | 19 % | |
| Dose-fractionation schema to PTV | |||
| 33–36 Gy/12–17 fx | 7 | 13 % | |
| 37.5 Gy/14–15 fx | 33 | 62 % | |
| 39–42 Gy/12–15 fx | 4 | 8 % | |
| 42.5 Gy/17 fx | 3 | 6 % | |
| 45 Gy/15 fx | 6 | 11 % | |
| Simultaneous integrated boost | 39 | 74 % | |
| Targets for which EQD2α/β=3 ≥ 54 Gy | 34 | 64 % | |
EQD2α/β=3 ≥ 54 Gy: Prescription dose to GTV was equal to or greater than 54 Gy, fx: fraction, GTV: gross tumor volume, n = number of patients, PTV: planning target volume.